| Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc |
| Journal website https://www.journalmc.org |
Case Report
Volume 13, Number 4, April 2022, pages 168-171
COVID-19 Presenting With a Challenging Combination of Thrombocytopenia and Thrombosis
Tables
| Proposed mechanisms of thrombocytopenia | References |
|---|---|
| COVID-19: coronavirus disease 2019; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2. | |
| Direct inhibition of hematopoiesis through binding to angiotensin-converting enzyme-2 on hematopoietic tissues and organs | Xu et al [3], Zhang et al [4], Mei et al [7] |
| The inflammatory cytokine-mediated destruction of hematopoietic progenitor cells | Xu et al [3] |
| The inflammatory cytokine-mediated inhibition of hematopoiesis or megakaryocytopoiesis | Zhang et al [4], Mei et al [7] |
| Decreased production of thrombopoietin either by damaged liver cells or inflammation | Zhang et al [4] |
| Block release of platelets from megakaryocytes in capillary beds of consolidated lung | Xu et al [3], Zhang et al [4] |
| Damaged endothelium triggers platelet aggregation and microthrombi formation and thereby increasing platelet consumption | Xu et al [3], Zhang et al [4], Mei et al [7] |
| Viral-mediated platelet-leukocyte aggregation | Wool et al [1] |
| SARS-CoV-2-induced autoimmune destruction of platelets | Xu et al [3], Zhang et al [4], Mei et al [7] |
| Hyperactivated platelets swallowed by hepatic/splenic macrophage | Mei et al [7] |
| Proposed mechanisms of thrombocytopenia | References |
|---|---|
| COVID-19: coronavirus disease 2019; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2. | |
| SARS-CoV-2 binds to ACE2 on host cell membrane by using its spike protein. Both SARS-CoV-2 and its spike protein can directly activate platelets leading to platelet aggregation and leukocyte-platelet aggregation subsequently leading to thrombus formation. | Zhang et al [13] |
| Immature platelets are elevated in COVID-19, which are functional and increase the risk of coagulopathy. | Wool et al [1] |
| COVID-19 triggers significant inflammatory reaction leading to endothelial damage and clot formation. | Wool et al [1] |